Global Cord Blood Corporation (CO): Detailed Summary on Healthcare Stock


Global Cord Blood Corporation (NYSE:CO) changes shares on Tuesday trading session, with a change of 1.16% or $0.04 shares. The trading starts at $3.40 and closed at $3.45 throughout the day. The trading session low price was $3.40 and day high was $3.55 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.13 million while its average volume is 216.97K. In other hand, the CO market cap reached to $427.94M.

On June 29, 2020, BRIEF-Global Cord Blood Q4 Earnings Per Share RMB 0.80. According to the news reported on Reuters, * ORATION REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR OF FISCAL 2020

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 2.95% and up 14.80% for month. Its quarterly performance was 26.45% above, while its half year performance is down -28.48%. CO yearly performance stood at negative -36.78% and fall -30.20% for year-to-date. Current recommendation for Global Cord Blood Corporation is 2.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CO EPS (TTM) for 12-month is 0.55. EPS for this year is 61.50%, while for the next year its value is 0.58. Sales growth for the current quarter is 0.21 while its EPS Q/Q reached 8.80%. It has an EPS of 23.30% up for past five years and for the next five years will be up 30.00%.

Let’s take a look on the analyst recommendations on CO for the current month and previous month. For the current month, 1 of 1 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $15.00 – $15.00. Average target price for CO was reached at $15.00.

The insider ownership moved to 49.60% and institutional holding shifted to 16.50%.

The company posted an EPS (TTM) of 0.55. According to the most recent quarter report on (Mar 2018), 1 analysts estimated an average EPS of 0.13. Analyst Estimated EPS for CO published in the report was $0.13 – $0.13 during the same period.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CO fall -10.55% for period of 200 days. SMA for 50 days was 11.59% which is showing green signal, while SMA-20 was 2.51%. The moving average value for Global Cord Blood Corporation (CO) is 26.49k and 0.17% for 200 and 50 days respectively.